Effect of calcineurin inhibitor on post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with liver transplantation: a propensity-matched cohort study
Hyoung-Chul Oh, Jeffrey J. Easler, Ihab I. El Hajj, James Watkins, Evan L. Fogel, Lee McHenry, Stuart Sherman, Hyun Kang, Glen A. Lehman
Korean J Intern Med. 2020;35(6):1364-1370. Published online 2020 Feb 19 DOI: https://doi.org/10.3904/kjim.2019.444
Citations to this article as recorded by 
A review of the rationale for the testing of the calcineurin inhibitor tacrolimus for post-ERCP pancreatitis prevention
Monique T. Barakat, Asna Khalid, Mang Yu, Ying Ding, Judy-April Murayi, Thottala Jayaraman, Ronald Poropatich, Venkat Akshintala, Wassem Juakiem, Li Wen, Georgios I. Papachristou, Sohail Z. Husain
Pancreatology.2022; 22(6): 678. CrossRef
Rectal INdomethacin, oral TacROlimus, or their combination for the prevention of post-ERCP pancreatitis (INTRO Trial): Protocol for a randomized, controlled, double-blinded trial
Venkata S. Akshintala, Sohail Z. Husain, Todd A. Brenner, Anmol Singh, Vikesh K. Singh, Mouen A. Khashab, Christina J. Sperna Weiland, Erwin J.M. van Geenen, Nikhil Bush, Monique Barakat, Ananta Srivastava, Rakesh Kochhar, Rupjyoti Talukdar, Gajanan Rodge
Pancreatology.2022; 22(7): 887. CrossRef
Tacrolimus for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: a potential new target of old drug?
Seok Jeong
Clinical Endoscopy.2022; 55(5): 628. CrossRef